Antony Ceraulo

Lyon, FR 
Lyon, FR 

Overview

Antony Ceraulo practices practicing medicine in Lyon, France.

His clinical expertise encompasses Childhood Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), Leukemia, Pheochromocytoma, and Bone Marrow Aspiration.

He is actively involved in clinical research, co-authoring 17 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Lyon, France
Other Locations
Pierre-la-treiche, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Multicentre, Open-label, Phase I-II Study Evaluating the Combination of a MEK Inhibitor and a PDL1 Inhibitor in Pediatric and Adult Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma.
A Multicentre, Open-label, Phase I-II Study Evaluating the Combination of a MEK Inhibitor and a PDL1 Inhibitor in Pediatric and Adult Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma.
Enrollment Status: Completed
Publish Date: April 23, 2026
Intervention Type: Drug
Study Drugs: Cobimetinib, Atezolizumab
Study Phase: Phase 1/Phase 2

17 Total Publications

Correction to: Safety and dosimetry of [177Lu]Lu-DOTA-TATE in adolescent patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours, or pheochromocytomas and paragangliomas: Primary analysis of the Phase II NETTER-P study.
Correction to: Safety and dosimetry of [177Lu]Lu-DOTA-TATE in adolescent patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours, or pheochromocytomas and paragangliomas: Primary analysis of the Phase II NETTER-P study.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 27, 2025

Frequently Asked Questions about Antony Ceraulo

Is Antony Ceraulo a top-rated expert for Childhood Acute Myeloid Leukemia?

MediFind is an objective health platform that identifies experts based on real-world data. Antony Ceraulo is classified as an Experienced expert for Childhood Acute Myeloid Leukemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Antony Ceraulo participate in research or clinical trials?

Yes. Antony Ceraulo has published 17 articles and abstracts on conditions like Childhood Acute Myeloid Leukemia. You can view a list of Antony Ceraulo's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ceraulo's expertise for a condition
ConditionClose
        View All 17 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile